iSpecimen Inc.
ISPCNASDAQHealthcare● Active
$2.95
$-0.07(-2.32%)
Market Cap$409643
P/E Ratio—
52W High$127.2
52W Low$2.9
iSpecimen Inc. (ISPC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ISPC · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.93M | $9.29M | $9.93M | $10.40M | $11.14M |
| Cost of Revenue | $1.90M | $5.30M | $4.82M | $4.76M | $5.25M |
| Gross Profit | $0.02M | $3.99M | $5.11M | $5.65M | $5.89M |
| Gross Margin %(computed) | 1.25% | 42.93% | 51.45% | 54.27% | 52.86% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $3.53M | $3.57M | $2.66M | $1.84M |
| G&A Expenses | $3.47M | $7.70M | $7.72M | $8.93M | $6.98M |
| Total Operating Expenses | $9.00M | $16.72M | $16.28M | $15.83M | $11.81M |
| Operating Income | ($8.98M) | ($12.73M) | ($11.17M) | ($10.19M) | ($5.93M) |
| Operating Margin %(computed) | -465.42% | -136.99% | -112.50% | -97.92% | -53.21% |
| Interest Income | $0.00M | $0.04M | $0.34M | $0.17M | $0.01M |
| Interest Expense | $0.00M | $0.22M | $0.23M | $0.24M | $2.10M |
| Income Before Tax | ($10.49M) | ($12.50M) | ($11.10M) | ($10.25M) | ($8.96M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($10.49M) | ($12.50M) | ($11.10M) | ($10.25M) | ($8.96M) |
| Net Margin %(computed) | -543.68% | -134.51% | -111.80% | -98.50% | -80.48% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-91.20 | $-703.20 | $-49.20 | $-818.80 | $-980.40 |
| Wtd Avg Shares | 0.12M | 0.02M | 0.01M | 0.01M | 0.01M |
| EBITDA | ($8.75M) | ($12.73M) | ($8.80M) | ($8.80M) | ($5.86M) |
| EBITDA Margin %(computed) | -453.43% | -136.99% | -88.67% | -84.61% | -52.58% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more iSpecimen Inc. data
About iSpecimen Inc. (ISPC) Income Statement
iSpecimen Inc. (ISPC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ISPC reported revenue of $0.00B, gross profit of $0.00B (gross margin 1.25%), and net income of ($0.01B) — a net profit margin of -543.68%.
Frequently asked questions
ISPC · 4 questionsiSpecimen Inc. (ISPC) reported revenue of $0.00B for 2025, down 79.2% year-over-year.
ISPC revenueISPC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09